2seventy bio, Inc. (NASDAQ: TSVT) reported Q2 EPS of ($0.83), $0.20 better than the analyst estimate of ($1.03). Revenue for the quarter came in at $36.04 million versus the consensus estimate of $37.18 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.